AKT1 and cancer: GO and KEGG enrichment analysis showed that the target genes were mainly enriched in the MAPK signaling pathway, PI3K-AKT signaling pathway, proteoglycans in cancer signaling pathway, and the mTOR signaling pathway (Figures 6A–D).